Digital pathology
Paige
Digital pathology AI applications for cancer pathology, including Paige Prostate.
Last updated: June 5, 2026
Back to directoryMindpeak medical AI product profile
Digital pathology AI company offering diagnostic suites and biomarker-analysis tools for tissue image workflows.
Digital pathology
Best fit
Labs evaluating AI-assisted IHC scoring, biomarker quantification, and interoperable pathology AI across routine diagnostic or pharma workflows.
- Primary use case
- AI-assisted tissue image analysis for breast biomarkers, PD-L1, HER2, tumor detection, and pathology workflow support
- Audience
- Diagnostic pathology labs, breast pathology teams, pharma pathology groups, and digital pathology networks
- Risk level
- High
- Pricing signal
- Enterprise diagnostic-lab and biopharma pricing; request current regional and module terms.
- Official sources
- 4 official sources
Compare within workflow: Digital pathology · comparison shortlist · source index
Regulatory, privacy, evidence, and workflow lens
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Mindpeak as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Verify the exact module, intended use, CE-IVD or local status, ISO 13485 scope, and whether the planned workflow is diagnostic, research, pharma, or deployment-specific. |
|---|---|
| Privacy | Do not infer PHI terms from the public website privacy policy alone; require customer-contract, hosting, retention, access-control, scanner/LIS integration, and data-use terms. |
| Evidence | Review product-specific validation and publications for the tissue, stain, biomarker, scanner, patient population, and scoring threshold used in the lab. |
| Workflow | Map how AI hotspots, biomarker scores, tumor regions, and exceptions appear in the pathologist viewer and report before diagnostic use. |
Where Mindpeak fits
Mindpeak says it offers AI-powered pathology suites for diagnostic labs, including breast IHC scoring, PD-L1, HER2, prostate, onychomycosis, lymphocyte quantification, and peakDissect workflows, and states recognition including ISO 13485 certification and multiple CE-IVD products; its privacy policy provides website-level data-processing context that is separate from customer deployment terms.
Not for: Diagnostic deployment without module-specific regulatory review, scanner validation, pathologist oversight, and local lab quality controls.
What to verify before using Mindpeak
- Which Mindpeak suite or module is in scope: breast IHC, PD-L1, HER2, prostate, onychomycosis, lymphocyte quantification, peakDissect, or a biopharma workflow.
- CE-IVD, ISO 13485, RUO, local regulatory, and intended-use status for the exact module and geography.
- Scanner, image-management, LIS, stain, tissue, and reporting compatibility in the local lab workflow.
- How pathologists review hotspots, quantitative scores, tumor regions, exceptions, and final diagnostic responsibility.
Source links
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.
- www.mindpeak.ai
- www.mindpeak.ai / for-diagnostic-labs
- www.mindpeak.ai / privacy-policy
- www.mindpeak.ai / news / mindpeak-announces-first-ce-marked-fully-automated-software-to-support-breast-cancer-tissue-diagnosis
Related medical AI products
Digital pathology
PathAI
AI-enabled digital pathology platform with image management and algorithm access.
Digital pathology
Hologic Genius Digital Diagnostics
FDA-cleared digital cytology system combining volumetric imaging, Genius Cervical AI, image management, and cytologist or pathologist review.
Digital pathology
Ibex Medical Analytics
Clinical-grade AI pathology platform for cancer diagnostics and pathology workflow support.